Abstract: Utilizing formalin-fixed paraffin-embedded (FFPE) archival tissue, the most common form of tissue preservation in routine practice, for cytogenetic analysis using microarray comparative genomic hybridization (aCGH) remains challenging. We searched for a predictive factor of the performance of FFPE DNA in aCGH analysis. DNA was extracted from 63 FFPE archival tissue samples of various tissue types (31 breast cancers, 24 lung cancers, and 8 thyroid tumors), followed by aCGH analysis using high-density oligonucleotide microarrays. Tumor DNA from matched frozen samples and from FFPE samples after whole-genome amplification were also analyzed in 2 and 4 case, respectively. The derivative log ratio spread (DLRSpread) was used to assess the overall quality of each aCGH result. The DLRSpread correlated significantly with the double-stranded DNA ratio of tumor DNA, storage time, and the degree of labeling with Cy5 (P < 0.0001; correlation coefficients = À 0.796, 0.551, À0.481, respectively). Stepwise multiple linear regression analysis revealed that the doublestranded DNA ratio of tumor DNA is the most significant predictive factor of DLRSpread (regression coefficient = À0.4798; P = < 0.0001). The cytogenetic profiles of FFPE and matched frozen samples showed good concordance. Although the double-stranded DNA ratios were increased after wholegenome amplification, the DLRSpread was not improved. The double-stranded DNA ratio can be used to predict the performance of aCGH analysis for DNA from FFPE samples. Using this quality metric, valuable FFPE archival tissue samples can be utilized for aCGH analysis.
C omparative genomic hybridization (CGH) is an especially useful method for detecting chromosomal instability in tumor genomes, an important hallmark of cancer. 1 Recent technological advances have enabled higher-resolution CGH analysis through the use of highdensity microarrays. [2] [3] [4] [5] [6] [7] [8] [9] [10] However, utilizing formalin-fixed paraffin-embedded (FFPE) archival tissue for microarray CGH (aCGH) remains challenging because of DNA degradation, cross-linking between nucleic acid strands, formation of DNA adducts with histones or nucleic acid binding proteins, and breaking and depurination of DNA. 11, 12 Several groups have demonstrated the feasibility of performing aCGH analysis on DNA extracted from FFPE samples. [13] [14] [15] [16] [17] [18] [19] [20] FFPE is the most common form of tissue preservation in routine practice, and these samples are often associated with detailed pathologic data and clinical outcomes. Regarding the technical improvement in aCGH analysis with FFPE tissue, DeVries et al 21 reported that whole-genome amplification (WGA) of DNA isolated from FFPE tissue, by random priming, is robust and reproducible. Lyons-Weiler et al 22 presented a modified protocol for single-nucleotide polymorphism arrays and generated comparable results for fresh frozen tissues. Meanwhile, Hostetter et al 23 reported an improvement in aCGH analysis results for long-oligonucleotide microarrays when using DNase treatment to generate randomly fragmented DNA. Furthermore, Wang et al 24 showed that molecular inversion probe microarrays required small intact DNA and was suitable for aCGH analysis using FFPE samples. Recently, a 1-step chemical labeling method, called the universal linkage system (ULS), was developed in which DNA is fluorescently labeled at the N7 position of guanine without the need for enzymatic reaction, which is susceptible to the effects of DNA degradation, yielding precise, robust, and high-quality aCGH data. [25] [26] [27] However, a suitable predictor of the performance of DNA from FFPE samples in aCGH, which will prevent the wasting of sparse clinical samples and economic resources, is still lacking. Certain research groups have reported that a prequalifying polymerase chain reaction test can predict the performance of FFPE DNA on microarrays better compared with FFPE sample age. 28, 29 In this retrospective observational study, we search for a factor to predict performance of FFPE DNA in aCGH analysis by dissecting aCGH analysis results from 63 archival FFPE tissue samples; we show that the ratio of double-stranded DNA to total DNA (dsDNA ratio) is able to predict the performance of FFPE DNA in aCGH analysis better compared with other factors such as FFPE sample age. This quality metric simplifies aCGH quality control when using FFPE archival tissue samples, thereby improving cost-effectiveness.
MATERIALS AND METHODS

Tumor Samples and Clinical Information
Sixty-three FFPE tissue samples were obtained from the Department of Pathology, Nagasaki University Hospital. The samples included 31 invasive breast cancers, 24 adenocarcinoma of the lung, and 8 thyroid follicular tumors. Twenty-eight of the 31 invasive breast cancers and the 24 lung cancers formed part of the data set that we previously reported. 30, 31 Resected specimens were immediately fixed in 10% neutral-buffered formalin for 24 hours, processed, and embedded into paraffin blocks. Routine staining with hematoxylin and eosin were performed on 3-mm-thick sections of tissue cut from the FFPE blocks. Pathologic diagnoses were made by independent pathologists. 
DNA Extraction
Tumor DNA was extracted from each FFPE sample, as previously reported. 32 Briefly, samples were macrodissected using between 10 and 20 sections of 10 mm thickness. Tumor tissue areas containing >70% tumor cells, as identified by a guide-slide stained with hematoxylin, were selected and manually dissected using surgical scalpels. Paraffin removal was performed in 80% xylene, after which samples were washed twice with absolute ethanol. Deparaffinized tissue samples were spun down, after which the dried-up pellet was resuspended in 360 mL buffer ATL (QIAmp DNA Mini Kit; Qiagen, Dusseldorf, Germany) and incubated at 951C for 15 minutes. Samples were allowed to cool down to room temperature and subsequently digested with proteinase K for 3 days at 561C in a rotation oven with periodic mixing and adding of fresh proteinase K every 24 hours. DNA was extracted using the QIAmp DNA Mini Kit according to the manufacturer's instructions with some modifications. Briefly, 400 mL buffer ATL was added to the sample, which was then incubated at 701C for 10 minutes, followed by the addition of 400 mL absolute ethanol and mixing by vortex. The sample solution was placed into the spin column, followed by centrifugation for 1 minute at 8000g. The spin column was washed twice with 500 mL buffer AW1 by centrifugation at 8000g for 1 minute and washed with 80% ethanol by centrifugation at 14,000g for 3 minutes. Finally, the DNA was eluted with 55 mL nuclease-free water.
For frozen tissue samples, 3 to 4 samples of tumor tissue were collected, and DNA was isolated using the QIAmp DNA Mini Kit according to the manufacturer's instructions. For 4 of the breast cancer samples, 100 ng DNA extracted from FFPE tissue was used in each case for WGA using the GenomePlex Complete Whole Genome Amplification Kit (Sigma-Aldrich, St Louis, MO), followed by purification using the GenElute PCR Clean-up Kit (Sigma-Aldrich) following the manufacturer's instructions, so that the ratio of double-stranded to total DNA (dsDNA ratio) of the samples increased.
DNA was quantitated using the ratio of absorbance at 260 and 280 nm (A260/A280), and 260 and 230 nm (A260/A230) on a Nano Drop ND-2000 spectrophotometer (NanoDrop Technologies, Wilmington, DE). The double-stranded DNA concentration in each sample was quantitated on a Qubit fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, Carlsbad, CA) following the manufacturer's instructions.
aCGH Analysis
The Genomic DNA ULS Labeling Kit (Agilent Technologies, Palo Alto, CA) was used to chemically label 500 ng of DNA from each sample and 250 ng of reference female genomic DNA (Promega, Madison, WI) with Cy5 or Cy3 dye for 30 minutes at 851C, respectively, followed by purification using Agilent-KREApure columns. The amount of input DNA was determined on a Qubit fluorometer using the Qubit dsDNA HS Assay Kit. The degree of Cy5 labeling (absorbance at 650 nm) was calculated using a Nano Drop ND-2000 spectrophotometer. Purified, labeled samples were then combined and mixed with human Cot-1 DNA (Invitrogen, Carlsbad, CA), Agilent 10Â Blocking Agent, and Agilent 2Â Hybridization Solution. Before array hybridization, hybridization mixtures were denatured at 951C for 3 minutes and incubated at 371C for 30 minutes. Agilent CGHblock was added, and samples were hybridized to the SurePrint G3 Human CGH 8Â 60 K Microarray (Agilent Technologies, Santa Clara, CA), which contains 8 identical arrays consisting of B63,000 in situ synthesized 60-mer oligonucleotide probes that span coding and noncoding sequences with an average spatial resolution of B54 kbp. Hybridization was carried out at 651C for 40 hours before washing with Agilent Oligo aCGH Wash Buffer 1 at room temperature for 5 minutes, followed by washing with Agilent Oligo aCGH Wash Buffer 2 at 371C for 1 minute. Scanning and image analysis were performed on an Agilent DNA Microarray Scanner. Agilent Feature Extraction Software (version 9.5) was used for data extraction from raw microarray image files. Agilent Genomic Workbench (version 5.0) was used to visualize, detect, and analyze chromosomal patterns using the Aberration Detection Method 2 (ADM-2) algorithm with the default settings. The derivative log ratio spread (DLRSpread) of each sample was also calculated using Agilent Genomic Workbench (version 5.0). A copy number gain or loss was defined as a log 2 ratio >0.25 or <À 0.25, respectively.
Statistical Analysis
The DLRSpread, which estimates the log ratio noise by calculating the spread of log ratio differences between consecutive probes along all chromosomes, was used to assess the overall quality of each aCGH result, with a lower value indicating a better result.
To search for predictive factors of the performance of FFPE DNA in aCGH analysis, the Spearman rank correlation was used to evaluate the relationship between DLRSpread and A260/A280 ratio, A260/A230 ratio, dsDNA ratio, storage time, and degree of labeling (Cy5) for each sample. For the DLRSpread, multiple regression analysis with stepwise selection was used to examine the associations with A260/A280 ratio, A260/A230 ratio, dsDNA ratio, storage time, and degree of labeling (Cy5) for each sample. These statistical analyses were performed using SAS statistical software (version 9.2; SAS Institute Inc., Cary, NC). Reported P-values are 2-sided, and those <0.05 were considered to be statistically significant.
RESULTS aCGH Analysis
Regarding the quality of DNA extracted from FFPE tissue, the mean dsDNA, A260/280, and A260/ A230 ratios were 0. 30 For the 2 breast cancer cases for which matched fresh frozen tissue was available, the cytogenetic profiles of FFPE and matched fresh frozen samples showed good concordance (Fig. 1) . For the 31 breast cancer samples, we compared the amplification status results for HER2 from aCGH and FISH to confirm the validity of using FFPE samples for aCGH. HER2 amplification was identified in 11 of 28 samples using FISH. Using aCGH, 8 of these 11 samples had log 2 ratios >0.25 for probe sets corresponding to the HER2 gene (A_14_P121276, A_14_P114826, and triplicate of A_16_P20643178), which met our criteria for a copy number gain. The sensitivity, specificity, and overall accuracy for the HER2 gene were 81.8%, 94.1%, and 89.3%, respectively (Supplementary Table 1 
Investigating Predictive Factors of DLRSpread
To determine factors predictive of DLRSpread, Spearman rank correlations between DLRSpread and the other factors were calculated. The dsDNA ratio and degree of labeling of DNA (Cy5) were significantly negatively correlated (P < 0.0001; r s = À 0.796 and À 0.481, respectively), whereas storage time was significantly positively correlated (P < 0.0001; r s = 0.551) with DLRSpread. The A260/A280 ratio was positively correlated, although not significantly so (P = 0.0589, r s = 0.237) ( Table 1) .
To elucidate the effect of each factor on DLRSpread, a stepwise multiple linear regression analysis was conducted, because each factor correlated with every other factor to some extent ( Table 2 ). The adjusted R 2 value was 0.53. Of the selected variables, the dsDNA ratio had the most significant effect on DLRSpread (regression coefficient À 0.4798 ± 0.0914; P < 0.0001), whereas the degree of labeling of DNA (Cy5) had a mild yet significant effect on DLRSpread (regression coefficient À 0.1796 ± 0.047; P = 0.0003) ( Fig. 2; Table 3 ).
The Effect of WGA on aCGH Analysis
For the 4 FFPE breast cancer samples for which WGA was performed, the dsDNA ratio for each sample was successfully increased. However, the degree of DNA labeling (Cy5) was slightly decreased, and the DLRSpread was increased compared with the original DNA (Table 4; Figure 1) . Thus, the increase in dsDNA ratio by WGA did not improve the quality of aCGH analysis using DNA extracted from FFPE tissues.
DISCUSSION
The wealth of clinical samples and comprehensive clinical information, such as clinical outcomes, associated with FFPE archival tissue, make these samples an attractive source for research. In fact, scarce clinical samples are often only available in the FFPE as opposed to the snap frozen form. However, utilizing FFPE tissues for molecular cytogenetic analysis is challenging because of 
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Predictive Factor of aCGH Analysis Quality DNA degradation caused by exposure to formaldehyde and acidic environments associated with the fixation and preservation process. Enzymatic fluorescence labeling is especially susceptible to the effects of DNA degradation. The ULS labeling system, which labels DNA nonenzymatically, is therefore an ideal method for aCGH analysis with degraded samples.
In this study, we conducted aCGH analysis on various types of cancer archival tissue samples using the ULS labeling system. Our aCGH results, which had a mean DLRSpread of 0.45 and an overall accuracy of 89.3% for the HER2 gene, were comparable to the results from former aCGH studies using FFPE archival tissue, although relatively lower in quality compared with that expected from DNA from fresh frozen tissue or peripheral blood lymphocytes. 16, 17, 23 Remarkably, very old archival tissue, preserved for >20 years, could still generate meaningful data. Nevertheless, FFPE samples tend to generate poor aCGH results, which indicate the importance of identifying a predictive factor for the performance of FFPE DNA in aCGH analysis.
According to the manufacturer's instructions for ULS labeling, sample quality is only assessed by A260/ A280 and A260/A230 ratios before labeling, thus DNA samples that show A260/A280 ratios of 1.8 to 2.0 and A260/A230 ratios of >2.0 are considered high-quality samples. The degree of labeling is used as a quality criterion for aCGH results with optimal ranges for Cy5 and Cy3 between 0.75% and 2.5%, and between 1.75% and 3.5%, respectively, with a Cy3 minus Cy5 range between 1% and 2%. However, our investigation revealed that neither the A260/A280 nor the A260/A230 ratio could predict aCGH performance. The degree of labeling can indeed predict aCGH performance, but aCGH performance cannot be predicted before the labeling step. Furthermore, a stepwise multiple linear regression analysis revealed that the dsDNA ratio was the most significant predictive factor of aCGH performance. According to the manufacturer's instructions for the ULS labeling system, the DLRSpread for FFPE samples should be <0.4, which corresponds to a dsDNA ratio of 0.3 according to our results. Hence, extremely old samples can be used for aCGH analysis when using the ULS labeling system, as long as the dsDNA ratio is >0.3.This finding is profoundly useful, because we can predict aCGH (Cy5) -0.481 (< 0.0001)
P-values are shown in parentheses. A260/A280 ratio indicates the ratio of the absorbance at 260 and 280 nm; A260/A230 ratio, the ratio of the absorbance at 260 and 230 nm; dsDNA ratio, the ratio of the amount of dsDNA and total DNA in tumor DNA. performance before the labeling step. This enables the user to predict which archival samples will generate highquality data before processing the samples, without wasting scarce specimen and financial resources.
From our results, we hypothesized that an increase in dsDNA ratio could improve aCGH performance when using the ULS labeling system. We then used the GenomePlex Whole Genome Amplification Kit, which generates a representative 500-fold amplification of genomic DNA using universal primers and optimized enzymes that decrease the background in the reaction, 33 to enlarge the dsDNA ratio of FFPE samples and compared the aCGH results. Disappointingly, the increase in dsDNA ratio did not translate to an improvement in DLRSpread, indicating that the poor performance of degraded DNA on aCGH platforms could not be attributed to the dsDNA ratio, but that the dsDNA ratio was an indicator of the degree of DNA degradation in the sample.
Recently, next-generation sequencing technologies have enabled novel findings with regard to the molecular architecture of human cancers. [34] [35] [36] [37] [38] [39] These technologies allow detection of not only DNA sequence changes, but also structural changes and copy number changes 40, 41 and can be used in routine clinical practice in some cases. 42 However, these technologies require high-grade DNA extracted from fresh or frozen samples, which is difficult to obtain, especially for rare patient cases. Furthermore, it remains costly to analyze and interpret huge data sets obtained through these technologies, although the related running costs are decreasing. In contrast, degraded DNA extracted from FFPE samples can be used for conventional Sanger sequencing and aCGH analysis, which may be sufficient for some molecular genetics analyses. Furthermore, the cost of aCGH analysis is much lower than that of next-generation sequencing technologies-for example, the aCGH platform used in this study, with about 60,000 probes, costs only $200 per sample. Therefore, when considering copy number analyses of FFPE samples and cost-effectiveness thereof, aCGH analysis remains an attractive option even in the era of next-generation sequencing.
In conclusion, the dsDNA ratio can be used to predict the performance of DNA from FFPE samples on the aCGH analysis when using the ULS labeling system. Using this quality metric, valuable FFPE archival tissue samples can be utilized for aCGH analysis without wasting scarce specimen and financial resources. 
